July 21 (Reuters) - IRLAB Therapeutics AB IRLBa.ST:
SAID ON FRIDAY 18,931,197 SHARES, ABOUT 48.7% OF RIGHTS ISSUE, WERE SUBSCRIBED FOR WITH SUBSCRIPTION RIGHTS IN RIGHTS ISSUE
4,838,083 SHARES, ABOUT 12.4% OF RIGHTS ISSUE, RECEIVED FOR SUBSCRIPTION OF SHARES WITHOUT SUBSCRIPTION RIGHTS
WILL GET PROCEEDS OF ABOUT SEK 115.7 MLN BEFORE DEDUCTION OF COSTS RELATED TO RIGHTS ISSUE, SET-OFF OF LOANS
Source text for Workspace: nMFNM2wvY
Further company coverage: [IRLABa.ST]
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))